Cargando…
M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma
In some highly inflammatory tumors, such as glioblastoma (GB), macrophages (MΦ) represent the most abundant population of reactive cells. MΦ, initially denoted as M0 MΦ, can be polarized into two further phenotypes: the antitumor M1 MΦ, and the protumor M2 MΦ. The three phenotypes can reside simulta...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641155/ https://www.ncbi.nlm.nih.gov/pubmed/29069812 http://dx.doi.org/10.18632/oncotarget.19994 |
_version_ | 1783271172380557312 |
---|---|
author | Leblond, Marine M. Pérès, Elodie A. Helaine, Charly Gérault, Aurélie N. Moulin, Damien Anfray, Clément Divoux, Didier Petit, Edwige Bernaudin, Myriam Valable, Samuel |
author_facet | Leblond, Marine M. Pérès, Elodie A. Helaine, Charly Gérault, Aurélie N. Moulin, Damien Anfray, Clément Divoux, Didier Petit, Edwige Bernaudin, Myriam Valable, Samuel |
author_sort | Leblond, Marine M. |
collection | PubMed |
description | In some highly inflammatory tumors, such as glioblastoma (GB), macrophages (MΦ) represent the most abundant population of reactive cells. MΦ, initially denoted as M0 MΦ, can be polarized into two further phenotypes: the antitumor M1 MΦ, and the protumor M2 MΦ. The three phenotypes can reside simultaneously in the tumor mass and various external factors may influence MΦ polarization. Radiotherapy is a common modality of cancer treatment aiming to target tumor cells. However, the specific effects of X-ray radiation on the inflammatory cells are, so far, controversial and not fully understood. In the present investigation, we have first analyzed, in vivo, the effect of X-ray radiation on MΦ present in GB tumors. We have observed a decrease in MΦ number paralleled by an increase in the proportion of M2 MΦ. To understand this phenomenon, we then evaluated, in vitro, the effects of X-rays on the MΦ phenotypes and survival. We have found that X-ray radiation failed to modify the phenotype of the different MΦ. However, M1 MΦ were more sensitive to ionizing radiation than M2 MΦ, both in normoxia and in hypoxia, which could explain the in vivo observations. To conclude, M2 MΦ are more radioresistant than M0 and M1 MΦ and the present study allows us to propose that X-ray radiotherapy could contribute, along with other phenomena, to the increased density in the protumor M2 MΦ in GB. |
format | Online Article Text |
id | pubmed-5641155 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56411552017-10-24 M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma Leblond, Marine M. Pérès, Elodie A. Helaine, Charly Gérault, Aurélie N. Moulin, Damien Anfray, Clément Divoux, Didier Petit, Edwige Bernaudin, Myriam Valable, Samuel Oncotarget Research Paper In some highly inflammatory tumors, such as glioblastoma (GB), macrophages (MΦ) represent the most abundant population of reactive cells. MΦ, initially denoted as M0 MΦ, can be polarized into two further phenotypes: the antitumor M1 MΦ, and the protumor M2 MΦ. The three phenotypes can reside simultaneously in the tumor mass and various external factors may influence MΦ polarization. Radiotherapy is a common modality of cancer treatment aiming to target tumor cells. However, the specific effects of X-ray radiation on the inflammatory cells are, so far, controversial and not fully understood. In the present investigation, we have first analyzed, in vivo, the effect of X-ray radiation on MΦ present in GB tumors. We have observed a decrease in MΦ number paralleled by an increase in the proportion of M2 MΦ. To understand this phenomenon, we then evaluated, in vitro, the effects of X-rays on the MΦ phenotypes and survival. We have found that X-ray radiation failed to modify the phenotype of the different MΦ. However, M1 MΦ were more sensitive to ionizing radiation than M2 MΦ, both in normoxia and in hypoxia, which could explain the in vivo observations. To conclude, M2 MΦ are more radioresistant than M0 and M1 MΦ and the present study allows us to propose that X-ray radiotherapy could contribute, along with other phenomena, to the increased density in the protumor M2 MΦ in GB. Impact Journals LLC 2017-08-07 /pmc/articles/PMC5641155/ /pubmed/29069812 http://dx.doi.org/10.18632/oncotarget.19994 Text en Copyright: © 2017 Leblond et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Paper Leblond, Marine M. Pérès, Elodie A. Helaine, Charly Gérault, Aurélie N. Moulin, Damien Anfray, Clément Divoux, Didier Petit, Edwige Bernaudin, Myriam Valable, Samuel M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma |
title | M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma |
title_full | M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma |
title_fullStr | M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma |
title_full_unstemmed | M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma |
title_short | M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma |
title_sort | m2 macrophages are more resistant than m1 macrophages following radiation therapy in the context of glioblastoma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641155/ https://www.ncbi.nlm.nih.gov/pubmed/29069812 http://dx.doi.org/10.18632/oncotarget.19994 |
work_keys_str_mv | AT leblondmarinem m2macrophagesaremoreresistantthanm1macrophagesfollowingradiationtherapyinthecontextofglioblastoma AT pereselodiea m2macrophagesaremoreresistantthanm1macrophagesfollowingradiationtherapyinthecontextofglioblastoma AT helainecharly m2macrophagesaremoreresistantthanm1macrophagesfollowingradiationtherapyinthecontextofglioblastoma AT geraultaurelien m2macrophagesaremoreresistantthanm1macrophagesfollowingradiationtherapyinthecontextofglioblastoma AT moulindamien m2macrophagesaremoreresistantthanm1macrophagesfollowingradiationtherapyinthecontextofglioblastoma AT anfrayclement m2macrophagesaremoreresistantthanm1macrophagesfollowingradiationtherapyinthecontextofglioblastoma AT divouxdidier m2macrophagesaremoreresistantthanm1macrophagesfollowingradiationtherapyinthecontextofglioblastoma AT petitedwige m2macrophagesaremoreresistantthanm1macrophagesfollowingradiationtherapyinthecontextofglioblastoma AT bernaudinmyriam m2macrophagesaremoreresistantthanm1macrophagesfollowingradiationtherapyinthecontextofglioblastoma AT valablesamuel m2macrophagesaremoreresistantthanm1macrophagesfollowingradiationtherapyinthecontextofglioblastoma |